{"title": "PFE - what is everyone doing with it?", "selftext": "Anyone getting out? I opened a position prob at the worst time a few months ago and down like 28 percent. Don’t need the money right now but wondering if the probably many years to recoup that is worth it or just exit and deploy into different positions.", "id": "18j7x9u", "created_utc": 1702667963.0, "score": 82, "upvote_ratio": 0.87, "num_comments": 100, "comments": [{"body": "[deleted]", "score": 87, "replies": [{"body": "Thats my strat aswell bought META at 110 when everybody said it was going to 30 and I am agressively buying PFE rn", "score": 51, "replies": [{"body": "[deleted]", "score": 20, "replies": [{"body": "I also bought ENPH at 90 very happy with that one so far!", "score": 13, "replies": [{"body": "I bought RBLX last quarter ((July) after it got crushed for earnings. Loaded up and sold after most recent earnings on October. Made 29%.\n\nGrabbed CHWY down 20% two weeks before earnings - made good cash there too.\n\nPerhaps I should look at PFE", "score": 7, "replies": []}, {"body": "Ugh my trade expired overnight for ENPH at 74. Back up to what originally looked like a bottom, 124, a few days later. Kicking myself.", "score": 3, "replies": []}]}, {"body": "I don’t like meta either but have held since 76.   Great stock", "score": 1, "replies": []}]}, {"body": "PFE is a pharmaceutical stock that gives dividends; it’s nowhere near comparable to META and won’t follow that big of a growth. That being said, I picked up about 50 shares at 26 because I’m an opportunist and the stock will surely outlive us probably. \n\nPFE handled the global distribution of covid vaccines amazingly and got a big chunk of change because of that. Hoping the M&A and R&D from Covid money pays off long run.", "score": 18, "replies": [{"body": "Distribution and manufacturing is a trait that other bio tech darlings like novo nordisk don’t do as well. Pfizer just has the industrial know how to pump out drugs, so even if they’re late to the punch on a drug class, like GLP-1, they’ll win out eventually just by being able to out produce the competition.", "score": 7, "replies": [{"body": "They’re also a savage company. I used to work for them and they’re ruthless. They’ll do anything for a $ and share price appreciation.", "score": 6, "replies": [{"body": "> share price appreciation \n\nthen whatever they are doing hasn’t worked for over a couple of decades", "score": 12, "replies": []}]}]}]}, {"body": "I got in on meta too but unsure about this one", "score": 2, "replies": []}]}, {"body": "They say you can't time the market but when companies with a long history of success drop in value dramatically it's almost always a good time to buy.", "score": 13, "replies": []}, {"body": "I also bought at sub 26. How are you automatically tracking oversold action?\n\nBetween intc, meta, boeing, I’ve found oversold action is the best.", "score": 4, "replies": [{"body": "[deleted]", "score": 5, "replies": [{"body": "I hear talk of RSI divergence, but when this happens, usually on the chart the price has bounced off a low and then returned to that same low. But since it didn’t fall from the same height the 2nd time, RSI doesn’t go as low, and you see a divergence.\n\nSo it makes me wonder how you distinguish this from what could just become the next leg of a downtrend. Is there a bounce you wait for?", "score": 2, "replies": []}]}]}, {"body": "What indicators do you use to pick up your entry?", "score": 1, "replies": []}]}, {"body": "Pfe is pharma giant going nowhere just buy", "score": 51, "replies": [{"body": "Agree.  Lol at these people thinking a single weight loss pill is going to shake PFE.", "score": 21, "replies": [{"body": "Lol that’s not the reason it’s dropping faster than my balls", "score": 9, "replies": [{"body": "Dont matter why it’s dropping or dropped look at long term, if you look at long term this is a buy opportunity not sell", "score": 2, "replies": []}]}]}, {"body": "250 shares at 27 \nI will drip the dividends and be patient", "score": 7, "replies": [{"body": "Depending on your trading style you could look to sell calls on your position for additional income", "score": 2, "replies": []}]}]}, {"body": "Doing a quick look, the stock price is at some of it's lowest levels in the past 10 years. Decent dividend and take 2022's financials off the table, company is pacing a bit better this year in profitability over previous years.\n\nIf I was invested, I'd probably DCA as much as possible. I actually am going to do some deeper DD this afternoon and take some of this money I have sitting on the sidelines and invest in it.\n\nEdit: 187.406 shares of PFE Limit at $26.68 - I just put $5K in.", "score": 38, "replies": []}, {"body": "At 88 shares with an average cost of $28.76. I’ll get it to 100 shares and then hold indefinitely.", "score": 20, "replies": []}, {"body": "it wasn’t long ago when the reddit ppl called out INTC dead when compared to the other semis :) if u got in at its low, youre sitting lovely right now. Ppl calling out PFE as if they dont have a pipeline.. acquisition is also a pipeline", "score": 18, "replies": [{"body": "I keep getting notifications about INTC hitting 52-wk highs.  \nNot sure where the bottom is for PFE, but I expect it to do the same as INTC eventually.", "score": 2, "replies": []}, {"body": "Just saw this response.  INTC not doing so hot.  Seems like going to revisit 20s again.  I am interested in PFE but am concerned about their high debt now and not sure if dividends sustainable with the current free cash flow.", "score": 1, "replies": []}]}, {"body": "Avoiding. Pfe is a persistent under-performer relative to the market and to XLV.\n\nOh, and they guided down eps by about 50%. Hard pass", "score": 37, "replies": [{"body": "Guiding down 50% to some degree derisks new entries at these levels. Normalization coming off covid year to be expected - albeit can not ignore the poor stock performance over past 5 yrs. That said, I entered with 100 shares and will sell covered calls and collect dividends while expect some share price returns from improved margins", "score": 3, "replies": [{"body": "It has been 23 years of poor performance \n\nI’m not suggesting Pfizer will be lower than it is today in 2-5 years. But I see no reason to believe it will reverse its underperformance to  xlv or voo. People are buying because it’s low, but it’s low because the business is not performing. That’s not attractive.", "score": 0, "replies": [{"body": "Appreciate the feedback\nIn response, PFE is a top 10 holding of XLV.\nI respect the diversification aspect of ETFs and utilize them in my portfolio for reasons including today UNH (#2 holding in XLV) tumbling >3% today w pressure on FY24 Pricing while PFE increased >1%. \nDespite PFE “being low”, I believe that risk is fully priced in and the downside risk is limited in comparison to upside potential. Based on my selling of covered calls i obviously realize upside is capped and am looking for income as i feel the market as a whole may be muted compared to recent returns. Cheers.", "score": 1, "replies": []}]}]}]}, {"body": "Honestly, unless you know biotech or pharma really well (like you work in the industry), don’t bet on anything. It’s always wildly unpredictable. But I do think PFE does look good at these levels since it looks quite oversold. However, there is a reason why the stock tumbled hard. Revenue forecasts are not looking really great", "score": 13, "replies": [{"body": "The only time you can *maybe* buy is when they have the drug approved and you think the market has not recognised the importance of the drug yet. For example, Novo Nordisk has approved drugs that are highly popular, if you think it's going to sell way more, then it will still be a buy.\n\nAside from that, speculating on trials is a total mess. Even the people working in those companies won't know whether something will pass trials and once they do, FDA approval isn't even guaranteed.", "score": 5, "replies": []}]}, {"body": "I'm averaging down from the low 50s. Got a ways to go. As long as they dont cut their dividend, I'll be fine", "score": 6, "replies": [{"body": "Raised by a penny", "score": 1, "replies": []}]}, {"body": "PFE is a low cost stock with a nice dividend. Company isnt going anywh (such as bankruptcy) but it seems there are better places to put money to work instead of this value trap. I would even prob prefer commodities rite now to PFE.", "score": 5, "replies": []}, {"body": "If you believed in the company a few months ago then why change your mind? You should buy more", "score": 12, "replies": []}, {"body": "Holding about 300 shares. May DCA some more.", "score": 7, "replies": []}, {"body": "Do they make money when the government does agree to buy all their shit is the real question. Some sure, enough to justify the market cap?\n\nFree market capitalism isn’t what drove the stock to an all time high. Government spending did. \n\nCan they perform without the government spending crutch", "score": 6, "replies": [{"body": "Are you talking about a single payer health system or something else?", "score": 1, "replies": [{"body": "No. I’m saying the government agreed to buy a shit ton of their stuff in recent years before it was even made so they had record profits. If the government wouldn’t of been involved and the individual had to pay they wouldn’t of moved nearly as much volume", "score": 2, "replies": []}]}]}, {"body": "One mans nightmare is another mans dream. I’ve opened a position in PFE this week along with BABA. Short term trades but don’t mind holding at these prices if it continues to tank( possibly add more).", "score": 6, "replies": [{"body": "Got screwed hard on baba\n\nNever buying Chinese stock again", "score": 20, "replies": [{"body": "I tell myself that but then keep swing trading baba and usually get burned, lol", "score": 1, "replies": []}]}]}, {"body": "Recent action looks like a capitulation event to me, similar to what Verizon saw back in July (though stock did briefly dip lower before going back up).  I think it’s worth taking a risk at these levels but have a stop-loss % in mind.  I think some Jan’25 LEAPs are looking cheap.", "score": 3, "replies": []}, {"body": "I'm down 28% on my PFE as well but  with div at $1.68 ($0.42 in Jan), I'll keep it for now.", "score": 3, "replies": []}, {"body": "These are fantastic prices to buy in. It is one of the largest pharmaceutical companies in the country and they have their fingers dipped in so many niches and markets (MUCH more outside of just COVID vaccines). You buy now you will have a guaranteed price appreciation if you can be patient while earning a decent dividend.", "score": 4, "replies": []}, {"body": "I’m holding", "score": 2, "replies": []}, {"body": "Tbh I would much rather have PFE than my current PYPL…. At least this shit pays dividend. Just hold it cause it will likely recover and it’s too big to fail imo", "score": 2, "replies": []}, {"body": "Average down while it’s in the 26’s and break even with the dividend. If you still want out then you’ll have at least minimized your losses. I don’t see Pfizer getting back to the high 30’s anytime soon. So just enjoy the ride for now.", "score": 2, "replies": []}, {"body": "I'm a divided investor and such stocks should perform well as interest rates decline. It's a good entry here for PFE even if it trades sideways, with dividend payers sideways is fine. I took a small position of 50 shares, if it drops more I'd grab a few more", "score": 2, "replies": []}, {"body": "I bought a few shares before the earnings call. Just waiting for 30 days so I can get out without the wash sale. Main thing was their weight loss pills, but if that’s not happening I’m out.", "score": 4, "replies": [{"body": "They still have the once a day oral weight loss pill, they pulled twice a day however if it’s the same molecule it doesn’t bode well.", "score": 2, "replies": []}]}, {"body": "DCA and sell calls when you get 100", "score": 5, "replies": [{"body": "Started that at $35.  Call side is trash unless right near the money.", "score": 2, "replies": [{"body": "Perhaps partially because of the dividend. But wasn’t it $35 like 2 weeks ago? How much and how often are you DCAing?", "score": 0, "replies": []}]}, {"body": "Exactly this.", "score": 1, "replies": []}]}, {"body": "Question is can it go lower?", "score": 3, "replies": [{"body": "Stock could always trade lower. However, considering that Pfizer is profitable company, trading around 10 year low, have been around for 100+ years.... trading lower is *probably* limited.", "score": 5, "replies": []}]}, {"body": "This pharma giant is not going out of business anytime soon. I'm holding this for the next 30 years and reinvesting the dividend.", "score": 1, "replies": []}, {"body": "Not owning it.", "score": 1, "replies": []}, {"body": "I love this post as it repeats itself every month and every few years  - just search the Reddit", "score": 1, "replies": []}, {"body": "I just bought some too cheap", "score": 1, "replies": []}, {"body": "bought some the other day for $26.xx", "score": 1, "replies": []}, {"body": "Eat it", "score": 1, "replies": []}, {"body": "I'm long with an average \"strike\" price of about $35. I'm looking to buy more monthly at these prices. It might be down sub $30 for a while, and I'm okay with it if they keep paying their dividend. They just need one big \"success\" to send this stock skyrocketing.", "score": 1, "replies": []}, {"body": "Sitting on 44b in cash. Guarantee they kick off 24 with a massive buyback.", "score": 1, "replies": [{"body": "They just made a $40 billion dollar acquisition.  I don't think buybacks are on the table", "score": 2, "replies": [{"body": "Huh yeah I know about Seagen, how does that work though? I know it was an all cash deal, is that paid on the deal closing? Or has it already been paid. Are they going to have 0 cash then going into 2024?\n\nEdit: Nvm they did it by taking on 30b in debt. I think the chances of a buyback are still likely. They said their focus after the acquisition was increasing buybacks and dividends.", "score": 2, "replies": []}]}]}, {"body": "Definitely not the worst possible time. Those of us buying 1-2 years have you beat. I’m just waiting it out, CEO seems pretty committed to improvement.", "score": 0, "replies": []}, {"body": "I sold at $30 for tax loss harvesting", "score": 0, "replies": []}, {"body": "Buying aggressively here.  This is the most punished stock, makes you think it's another enron unfolding", "score": 0, "replies": []}, {"body": "I would buy at$25.", "score": 0, "replies": []}, {"body": "Losing money, and they only have one med in the pipeline waiting for FDA approval. so, nothing sexy for the next 1-2 years.", "score": 0, "replies": []}, {"body": "Dayum ... this gonna be a penny stock.", "score": -4, "replies": []}, {"body": "I just opened a new position today. I’ve owned Pfizer before. Solid company that isn’t going anywhere trading at a bargain bin price. Hoping it drops lower, I’d like to buy a lot more.", "score": 1, "replies": []}, {"body": "It’s being priced as a mature company with very muted expectations for growth.", "score": 1, "replies": []}, {"body": "i've got like a 30.50 average, bought a bit before adn then last week at 28. i'd buy more now to avg down if I had the money. i imagine itll be back up eventually, probably not the best use of the money but not the worst.", "score": 1, "replies": []}, {"body": "bought a put recently and sold it for 2x the other day on the drop. Still a falling knife IMO", "score": 1, "replies": []}, {"body": "Why did you open a position? Do you not believe in your conviction to buy anymore?", "score": 1, "replies": []}, {"body": "Is there a chance they cut the dividend?", "score": 1, "replies": [{"body": "They just increased the dividend like a few days ago. No cut in sight so far", "score": 1, "replies": []}]}, {"body": "I’m selling covered calls on my shares (currently $32 strikes) And selling puts at 28.  So my entry price comes down a little every month.", "score": 1, "replies": []}, {"body": "Want out? Depending on how much losses you have and gains for 2023 tax purpose.\n\nThe analyst rating from different companies hint it is a solid C+ now. My holding started in 1997 and my cost basis is the same as trade price.  I see no reason to add since it will be 3-5 years before seeing a return.", "score": 1, "replies": []}, {"body": "I feel less bad than I did when I bought $CRM at $260 and it tanked. I ended up holding at the time and got my money back after selling the moment it went green.\n\nThis is will be another one of those stocks.", "score": 1, "replies": []}, {"body": "im absolutely buying.", "score": 1, "replies": []}, {"body": "Tax loss this year taken on Thursday.\n\nMaybe I buy it back in 30+ days for its secure dividend and probable eventual return to glory and a much higher price.\n\nNot feeling much urgency though.", "score": 1, "replies": []}, {"body": "I already got out", "score": 1, "replies": []}, {"body": "I'm slowly buying into it. If they keep paying the dividend, I don't mind the share price stagnating for a while. Can always sells covered calls on it, too.", "score": 1, "replies": []}, {"body": "Wishing I did not own.", "score": 1, "replies": []}, {"body": "For insight check out VZW.I see same trend.", "score": 1, "replies": []}, {"body": "Probably going to tax loss harvest before EOY for a 30% loss", "score": 1, "replies": []}, {"body": "A flagging stock from a monolith company with piss poor management. What good are the dividend incentives if the stock does not go up? \n\nRegardless, holding the bag until I make my money back.", "score": 1, "replies": []}]}
